Women with gestational diabetes who fail to meet blood sugar targets during pregnancy show measurably worse metabolic health after delivery, according to a prospective cohort study conducted at a maternal health center in Ma’anshan, China. The research, published open access in Diabetology & Metabolic Syndrome, followed women recruited during pregnancy and tracked their glucose and lipid profiles at 42 days and one year postpartum.
Glycemic management is standard care for the condition, but the authors note that its impact on postpartum metabolic health has remained uncertain, particularly for a subtype known as late-onset GDM, which is diagnosed later in pregnancy. The new study set out to test whether achieving glycemic control during pregnancy improves metabolic outcomes compared with women who do not achieve it.
Between June 2021 and December 2022, the researchers recruited 358 women with GDM and 750 controls without the condition at 24 to 28 weeks of gestation. Participants were then divided into four groups based on third-trimester fasting plasma glucose: women without GDM, women with GDM and normal glycemic control defined as fasting plasma glucose below 5.1 mmol/L, women with GDM and abnormal glycemic control, and women with late-onset GDM. Follow-up visits at 42 days and one year after delivery included questionnaires, physical examinations, and metabolic measurements, with the non-GDM group serving as the reference. Associations were analyzed using multivariate regression.
The results point to a clear pattern among the 642 participants followed at 42 days and the 736 followed at one year. Compared with women who did not have GDM, those with GDM and abnormal glycemic control had increased risks of blood glucose abnormalities, with an odds ratio of 5.22, and of triglyceride abnormalities, with an odds ratio of 2.43. In contrast, no significant associations were found for women with GDM who achieved normal glycemic control or for those with late-onset GDM.
The contrasts within the GDM groups were equally striking. When compared directly with women who had GDM but maintained normal control, those with abnormal control showed increased risks of 2-hour glucose abnormalities, with an odds ratio of 2.77, and of total cholesterol abnormalities, with an odds ratio of 2.97. These figures suggest that the difference in postpartum risk runs along the line of glycemic control achieved during pregnancy rather than simply along the presence of a GDM diagnosis.
The study’s summary findings describe women who failed to meet glycemic control targets as exhibiting significantly worse postpartum metabolic outcomes, including higher fasting plasma glucose, total cholesterol, and triglyceride levels, with poor control increasing the risk of glucose and lipid abnormalities up to one year after delivery. The authors interpret this as evidence that glycemic management during pregnancy improves postpartum metabolic outcomes and underscores the importance of GDM diagnosis and subsequent glycemic control.
One subgroup deserves particular attention. Women with late-onset GDM showed no significant associations with postpartum metabolic abnormalities in this analysis, a result the authors suggest may reflect different underlying mechanisms from those operating in GDM diagnosed earlier in pregnancy.
As with any observational cohort, the findings describe associations rather than proven causal effects of treatment, and the analysis focused on a single center in China with a defined recruitment window, so results may not generalize to all populations. Even so, the study adds a practical dimension to a well-established risk picture: gestational diabetes is associated with elevated postpartum metabolic risk, and the degree to which blood sugar targets are met during pregnancy appears to distinguish women who carry that risk forward from those whose profiles resemble women without the condition.
The authors conclude that strengthening clinical management after a GDM diagnosis could improve maternal metabolic health well beyond delivery, and their results support tailoring interventions according to when the condition arises during pregnancy. For clinicians and patients alike, the message is that the months between diagnosis and birth may shape metabolic health for at least a year afterward.
Subject of Research: Glycemic control during pregnancy and postpartum metabolic outcomes in women with gestational diabetes
Article Title: Association between glycemic management during pregnancy and postpartum metabolic health outcomes among women with gestational diabetes mellitus
Article References: Zhu, T., Dong, Y., Wang, L., Ding, Z., Zhao, L., Fan, T., Liu, J., Gao, H., Yan, S., Jia, X., Yang, F., Ren, J., Chen, L., Tao, F., & Zhu, B. (2026). Association between glycemic management during pregnancy and postpartum metabolic health outcomes among women with gestational diabetes mellitus. Diabetology & Metabolic Syndrome. https://doi.org/10.1186/s13098-026-02326-6
Image Credits: AI Generated
DOI: 10.1186/s13098-026-02326-6
Keywords: gestational diabetes, glycemic control, postpartum health, fasting plasma glucose, triglycerides, total cholesterol, late-onset GDM, cohort study, metabolic outcomes, pregnancy, Association, between
News Source: Harold Sullivan. (October 29, 2026). Poor Blood Sugar Control in Pregnancy Linked to Worse Postpartum Metabolic Health. Scienmag.
